Long-acting GHRH analogue with Drug Affinity Complex
5 studies
Open record →Free guide
Discover what really matters in facial optimization: structure, asymmetries, priorities and the mistakes that slow your progress the most.
Research Area
Regulação de GHRH, secreção de GH, IGF-1 e sinalização somatotrófica.
At a glance
Choose a level
pathway
Estratégia de extensão de exposição em que o grupo Drug Affinity Complex do CJC-1295 se associa à albumina circulante; albumina atua como carreador, não como receptor farmacológico.
pathway
Eixo endócrino que conecta sinalização hipotalâmica e pituitária à produção e ação de IGF-1.
pathway
Ativação de GHRHR em somatotrofos com sinalização Gs, adenilil ciclase, cAMP e PKA.
pathway
Rede de segundo mensageiro gerada por adenilil ciclase e interpretada por efetores como PKA e EPAC.
pathway
Sinalização do receptor secretagogo de GH e seus efeitos neuroendócrinos.
pathway
Cascata de receptor tirosina-quinase associada a crescimento, sobrevivência e metabolismo celular.
cell type
Anterior-pituitary cells that synthesize and release growth hormone.
cell type
Bone-forming cells that synthesize osteoid and participate in mineralization.
cell type
Multinucleated cells specialized for resorption of mineralized bone.
cell type
Mature bone cells embedded in matrix that participate in mechanosensing and remodeling signals.
cell type
Primary cell type responsible for cartilage matrix formation and growth-plate activity.
cell type
Differentiated contractile muscle cells.
Connected records
Long-acting GHRH analogue with Drug Affinity Complex
5 studies
Open record →Catalogue term often associated with Modified GRF (1–29)
0 studies
Open record →GHRH(1–29) analogue
0 studies
Open record →Stabilized GHRH analogue
1 study
Open record →Selective ghrelin receptor agonist
0 studies
Open record →Growth hormone secretagogue
0 studies
Open record →Growth hormone secretagogue
0 studies
Open record →Growth hormone secretagogue
0 studies
Open record →Insulin-like growth factor 1
0 studies
Open record →Long R3 IGF-1 analogue
0 studies
Open record →N-terminal IGF-1 fragment
0 studies
Open record →Published evidence